Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jeffrey V Ravetch

33PUBLICATIONS
137CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

Sort by Publication Date:
|Apr 08, 2026
Selective depletion of virus-specific CD8 T cells from the liver after PD-1 therapy with Fc-intact antibody during chronic infection.

Masao Hashimoto, Tahseen H Nasti, Hyun-Tak Jin

|Dec 16, 2025
Antibody-lectin chimeras for glyco-immune checkpoint blockade.

Jessica C Stark, Melissa A Gray, Itziar Ibarlucea-Benitez

|Dec 12, 2025
Asymmetrically glycosylated IgG1 antibodies are universal and drive human disease.

Tala Azzam, Stylianos Bournazos, Hasret Gunduz

|Nov 06, 2025
The anti-inflammatory activity of IgG is enhanced by co-engagement of type I and II Fc receptors.

Andrew T Jones, Alessandra E Marino, Tetyana Martynyuk

|Jul 03, 2025
The mechanistic basis for interprotomer deglycosylation of antibodies by corynebacterial IgG-specific endoglycosidases.

Diego E Sastre, Stylianos Bournazos, Maros Huliciak

|Jul 01, 2025
FcγRIIIa is a noncanonical costimulatory molecule for CD8 T cells.

Kevin S Kao, Nicole L Pihlstrom, Emily G Niejadlik

Pageof 6

Frequent Collaborators

9 joint publications

Stylianos Bournazos

4 joint publications

Eric J Sundberg

3 joint publications

David A Knorr

3 joint publications

Jonathan J Du

3 joint publications

Andrew T Jones

3 joint publications

Charles M Rice

2 joint publications

Polina Weitzenfeld

2 joint publications

Hans-Heinrich Hoffmann

2 joint publications

Tineke Cantaert

2 joint publications

Timothy P Sheahan

Frequent Collaborators

9 joint publications

Stylianos Bournazos

4 joint publications

Eric J Sundberg

3 joint publications

David A Knorr

3 joint publications

Jonathan J Du

Top Related Videos

<em>In Vitro</em> Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
09:26

<em>In Vitro</em> Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on : Oct 15, 2013

14.6K
Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques
08:58

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques

Published on : Jul 05, 2018

13.1K
Antibody Binding Specificity for Kappa (V&#954;) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
11:10

Antibody Binding Specificity for Kappa (V&#954;) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study

Published on : Jun 29, 2016

14.5K
See more related videos

Top Related Videos

<em>In Vitro</em> Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
09:26

<em>In Vitro</em> Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on : Oct 15, 2013

14.6K
Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques
08:58

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques

Published on : Jul 05, 2018

13.1K
Antibody Binding Specificity for Kappa (V&#954;) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
11:10

Antibody Binding Specificity for Kappa (V&#954;) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study

Published on : Jun 29, 2016

14.5K
See more related videos